CINECA IRIS Institutional Research Information System

IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.

Prodotti recenti

Centrality dependence of high-pT D meson suppression in Pb-Pb collisions at (Formula presented.) TeV

Addendum to: Centrality dependence of high-pT D-meson suppression in Pb-Pb collisions at √sNN=2.76 TeV

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Therapeutic re-challenge is currently a debated issue in the field of multiple myeloma (MM), given the recent availability of several new drugs and combinations. However, very few specific evidences are available about bortezomib re-use at first relapse. This multicenter, observational, retrospec...

CINECA IRIS Institutional Research Information System

Prodotti recenti

Centrality dependence of high-pT D meson suppression in Pb-Pb collisions at (Formula presented.) TeV

Addendum to: Centrality dependence of high-pT D-meson suppression in Pb-Pb collisions at √sNN=2.76 TeV

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

One-dimensional pion, kaon, and proton femtoscopy in Pb-Pb collisions at s NN =2.76 TeV

Enhanced production of multi-strange hadrons in high-multiplicity proton-proton collisions

Scopri